Rare diseases
Investigational molecules
Locations
Back to Spain132 clinical trials in Jaen, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
SpainStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
SpainStudy on the Effectiveness and Safety of a Grass and Olive Pollen Allergy Vaccine for Patients with Allergic Rhinitis or Asthma
SpainStudy of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
SpainStudy on Durvalumab, Paclitaxel, Carboplatin, and Olaparib for Patients with Advanced or Recurrent Endometrial Cancer
SpainStudy on Chemotherapy-Free Treatment with Trastuzumab, Pertuzumab, and T-DM1 for Patients with HER2-Positive Early-Stage Breast Cancer
SpainSpainStudy on Diarrhea Discontinuations in Early-stage HER2+ Breast Cancer Patients Treated with Neratinib, Loperamide, and Colesevelam
SpainStudy of EOS884448, Dostarlimab, and Inupadenant for Patients with Advanced Solid Tumors
SpainStudy of SBP-101, Nab-Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer
SpainStudy of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer
SpainStudy Comparing Dostarlimab and Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Multiple studies focusing on non-small cell lung cancer and small cell lung cancer treatments, investigating novel combination therapies and targeted approaches for different disease stages.
Research emphasizes improving survival rates through innovative therapeutic approaches for both extensive and limited-stage disease.
Comprehensive research into HER2-positive and hormone receptor-positive breast cancer, exploring new treatment combinations and targeted therapies.
Studies focus on both early-stage and metastatic disease, with emphasis on personalized treatment approaches.
Diverse research covering hepatocellular carcinoma, bladder cancer, and other solid tumors, evaluating novel therapeutic strategies.
Investigations aim to improve treatment outcomes across multiple cancer types using cutting-edge therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
